Rapid amplification of cDNA ends (RACE) improves the PCR-based isolation of immunoglobulin variable region genes from murine and human lymphoma cells and cell lines

Leukemia

Volumn 11, Issue 10, 1997, Pages 1787-1792

  Doenecke, A ^a   Winnacker, E L ^a   Hallek, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Consensus primer; Immunoglobulin variable region; Polymerase chain reaction; RACE PCR

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN HEAVY CHAIN; OLIGONUCLEOTIDE;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR CLONING; MOUSE; MYELOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030684119     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400781     Document Type: Article

References (24)

1. Straka C, Pettengell R, Pielmeier A et al. A reliable approach for sequencing clone-specific CDRIII regions in B cell lymphoma. Ann Oncol 1994; 1: 79-84.
2. Yamada M, Hudson S, Tournay O et al. Detection of minimal disease in hematopoietic malignancies of the B cell lineage by using third complementarity determining region (CDR-I)-specific probes. Proc Natl Acad Sci USA 1989; 86: 5123-5127.
3. Stevenson FK, Zhu D, King CA, Ashworth LJ, Kumar S, Hawkins RE. Idiotypic DNA vaccines against B cell lymphoma. Immunol Rev 1995; 145: 211-228.
4. Kettleborough CA, Saldanha J, Ansell KH, Bendig MM. Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. Eur J Immunol 1993; 23: 206-211.
5. Orlandi R, Gussow DH, Jones PT, Winter C. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 3833-3837.
6. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest, Vol 2, 5th edn. US Department of Health and Human Services: Public Health Service, National Institutes of Health, Bethesda, 1991.
7. Linke B, Bolz I, Pott C, Hiddemann W, Kneba M. Use of UlTma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions. Leukemia 1995; 9: 2133-2137.
8. McCarthy KP, Sloane JP, Wiedemann LM. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 1990; 43: 429-432.
9. Aubin J, Davi F, Nguyen SF et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995; 9: 471-479.
10. Deftos M, Soto GR, Quan M, Olee T, Chen PP. Utilization of a potentially universal downstream primer in the rapid identification and characterization of V lambda genes from two new human V lambda gene families. Scand J Immunol 1994; 39: 95-103.
11. Dubel S, Breitling F, Fuchs P et al. Isolation of IgG antibody FvDNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers. J Immunol Meth 1994; 175: 89-95.
12. Hawkins RE, Zhu D, Ovecka M et al. Idiotypic vaccination against human B cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 1994; 83: 3279-3288.
13. Ruberti F, Cattaneo A, Bradbury A. The use of the RACE method to clone hybridoma cDNA when V region primers fail. J Immunol Meth 1994; 173: 33-39.
14. Levy R, Levy S, Cleary ML et al. Somatic mutation in human B cell tumors. Immunol Rev 1987; 96: 43-58.
15. Kim KJ, Kanellopoulos LC, Merwin RM, Sachs DH, Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 1979; 122: 549-554.
16. Frohman MA, Dush MK, Martin GR. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 1988; 85: 8998-9002.
17. Weiss S, Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell 1991; 64: 767-776.
18. Corradini P, Voena C, Omede P et al. Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia 1993; 7: 1879-1882.
19. Ebeling SB, Schutte ME, Akkermans KK, Bloem AC, Gmelig MF, Logtenberg T. Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. Int Immunol 1992; 4: 313-320.
20. Hakim I, Amariglio N, Brok SF et al. Preferred usage of specific immunoglobulin gene segments in chronic lymphocytic leukaemia cells of three HLA-identical sisters. Br J Haematol 1995; 91: 915-917.
21. Hsu FJ, Levy R. Preferential use of the VH4 lg gene family by diffuse large-cell lymphoma. Blood 1995; 86: 3072-3082.
22. Deane M, Norton JD. Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B lineage leukaemias. Leukemia 1991; 5: 646-650.
23. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989; 86: 5913-5917.
24. Sasso EH, Willems vDK, Bull AP, Milner EC. A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles. J Clin Invest 1993; 91: 2358-2367.